Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NVSEF - Greenwich LifeSciences Files For U.S. IPO

NVSEF - Greenwich LifeSciences Files For U.S. IPO

Novartis Ag Basel Akt

Quick Take

Greenwich LifeSciences (GLSI) has filed to raise $23.5 million in an IPO of its common stock, according to an S-1 registration statement.

The firm is developing an immunotherapy designed to prevent the recurrence of breast cancer.

GLSI is preparing to enter Phase 3 trials in 2020 for its sole candidate.

I’ll provide a final opinion when we learn management’s pricing and valuation assumptions for the IPO.

Company & Technology

Stafford, Texas-based Greenwich was founded to develop an adjuvant therapy for patients with HER2/neu 3+ breast cancer in conjunction with Herceptin.

Management

Read more ...
Stock Information
Company Name: Novartis Ag Basel Akt
Stock Symbol: NVSEF
Market: OTC
Website: novartis.com
Menu
NVSEF NVSEF Quote NVSEF Short NVSEF News NVSEF Articles NVSEF Message Board
Get NVSEF Alerts

News, Short Squeeze, Breakout and More Instantly...